Comparative Efficacy and Tolerability of Antimuscarinic Agents and the Selective β3-Adrenoceptor Agonist, Mirabegron, for the Treatment of Overactive Bladder: Which is More Preferable as an Initial Treatment?-Reference-Cited by-同舟云学术

Comparative Efficacy and Tolerability of Antimuscarinic Agents and the Selective β3-Adrenoceptor Agonist, Mirabegron, for the Treatment of Overactive Bladder: Which is More Preferable as an Initial Treatment?

Published:2016-12-23 Issue:2 Volume:10 Page:158-166
ISSN:1757-5664
Container-title:LUTS: Lower Urinary Tract Symptoms
language:en
Short-container-title:Lower Urinary Tract Symptoms

Author:

KOBAYASHI Minoru¹,NUKUI Akinori²,KAMAI Takao³

Affiliation:

1. Department of Urology; Utsunomiya Memorial Hospital; Utsunomiya Japan

2. Department of Urology; Nasu Red Cross Hospital; Ohtawara Japan

3. Department of Urology; Dokkyo Medical University; Mibu Japan

Publisher

Wiley

Subject

Urology,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/luts.12153/fullpdf

Reference28 articles.

1. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment;Gormley;J Urol,2015

2. The forefront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: ameliorative effect of solifenacin succinate (Vesicare), a bladder-selective antimuscarinic agent, on overactive bladder symptoms, especially urgency episodes;Ohtake;J Pharmacol Sci,2010

3. Comparison of fesoterodine and tolterodine extended release for the treatment of overactive bladder: a head-to-head placebo-controlled trial;Herschorn;BJU Int,2010

4. Antimuscarinics for treatment of storage lower urinary tract symptoms in men: a systematic review;Kaplan;Int J Clin Pract,2011

5. Persistence and adherence in the treatment of overactive bladder syndrome with anticholinergic therapy: a systematic review of the literature;Sexton;Int J Clin Pract,2011

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How can we explain the poor medication adherence in patients with overactive bladder syndrome?;Hellenic Urology;2024-07

2. A Comparison of U.S. Individual and Family Plan Medication Coverage for Overactive Bladder;Urogynecology;2024-03

3. Comparison Of Outcome And Side Effects Profile Of Treatment Of Overactive Bladder With Different Classes Of Drugs;Journal of Rawalpindi Medical College;2023-12-30

4. A Comparative Study on the effectiveness and Tolerability of Mirabegron and Antimuscarinics in the treatment of Overactive bladder;Research Journal of Pharmacy and Technology;2023-05-31

5. Comparison of antimuscarinic drugs to beta adrenergic agonists in overactive bladder: A literary review;Current Urology;2021-08-17